Table 1 Patients characteristics
| Â | PC20 | PC22 | AC22 | p value |
|---|---|---|---|---|
Number of patients | 111 | 68 | 12 | Â |
Age (years) (median, range) | 70 (40–87) | 71 (47–85) | 73 (52–80) | 0.69§ |
Sex | Â | Â | Â | 0.35# |
 Male | 59 (53.1%) | 37 (54.4%) | 9 (75%) |  |
 Female | 52 (46.9%) | 31 (45.6%) | 3 (25%) |  |
Anti-platelet/anti-coagulant agents | 12 (10.8%) | 11 (16.2%) | 3 (25%) | 0.29# |
Diabetes Mellitus | 32 (28.8%) | 24 (21.6%) | 2 (16.7%) | 0.37# |
Smoking | 16 (14.4%) | 8 (11.8%) | 3 (25%) | 0.47# |
Post-operative stomach | 1 (0.9%) | 1 (1.47%) | 0 (0%) | 0.87# |
Location of the pancreatic tumor | 0.88# | |||
 Head | 33 (29.7%) | 19 (28.0%) | 5 (41.7%) |  |
 Body | 56 (50.5%) | 37 (54.4%) | 5 (41.7%) |  |
 Tail | 22 (19.8%) | 12 (17.6%) | 2 (16.7%) |  |
Puncture line | 0.71# | |||
 Trans gastric | 85 (76.6%) | 50 (73.5%) | 8 (66.7%) |  |
 Trans duodenal | 26 (23.4%) | 18 (26.5%) | 4 (33.3%) |  |
Maximum diameter of tumor (mm) (mean ± SEM) | 37.9 ± 1.2*, $$$$ | 32.9 ± 1.2¶ | 22.7 ± 2.6 |  < 0.0001§ |
Maximum stroke length of puncture (mm) (mean ± SEM) | 30.6 ± 0.7$$ | 30.3 ± 0.8¶¶ | 22.1 ± 2.2 |  < 0.01§ |
Number of passes | 3.7 ± 0.9** | 4.1 ± 0.7¶ | 3.5 ± 0.6 |  < 0.01§ |